•  
  •  
  •  
  •  

2026-08-14 14:02:34

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Enviro Infra Engineers Reports 49.1% Revenue Growth to ₹ 3,592 Million in Q1 FY27; PAT Rises 6.5% to ₹ 452 Million
  • Wanbury Limited Reports Q1 FY27 Revenue of ₹165.6 Crore; Refinances ₹205 Crore Debt to Cut Interest Costs
  • Popular Vehicles & Services Reports 44.6% YoY Revenue Growth to ₹1,903.1 Crore in Q1 FY27; Turns Profitable with ₹1.4 Crore PAT
  • Hirect Limited Reports 20.3% Revenue Growth in Q1 FY27; Standalone Net Profit Up 17.8% Amid Global Expansion
  • Delton Cables reports highest ever first quarterly Revenue, EBITDA & PAT

Keywords Selected:  INE485C01011

Stock Report

  • EDQM issues CEP Certificate for IOL Chemicals and Pharmaceuticals Ltd's API Quetiapine Fumarate
  • EDQM issued CEP Certificate for MESALAZINE
  • IOL Chemicals and Pharmaceuticals Ltd board approves 5 For 1 Stock Split
  • Indian Chemical Council awarded Responsible Care® Logo to IOL Chemicals and Pharmaceuticals Ltd
  • EDQM issues CEP certificate to IOL Chemicals and Pharmaceuticals Ltd for Valsartan
  • NMPA, China approves Fenofibrate manufactured by IOL Chemicals and Pharmaceuticals Ltd
  • IOL Chemicals and Pharmaceuticals Ltd receives EDQM CEP certificate for Allopurinol
  • IOL Chemicals and Pharmaceuticals Ltd receives GMP Certificate issued by Brazilian Health Regulatory Agency ANVISA
  • IOL Chemicals and Pharmaceuticals Ltd successfully completes ANVISA GMP audit
  • IOL Chemicals and Pharmaceuticals Ltd's product approved by CDE of NMPA, China
  • IOL Chemicals and Pharmaceuticals Ltd rating reaffirmed to A+ by CARE Ratings
  • IOL Chemicals and Pharmaceuticals Ltd's Acetic Anhydride Plant goes on stream
  • IOL Chemicals and Pharmaceuticals receives CEP for Paracetamol to Export in European Market
  • IOL Chemicals and Pharmaceuticals appoints Vikas Vij as CEO
  • IOL Chemicals and Pharmaceuticals Limited announces board rejig
  • IOL Chemicals and Pharmaceuticals Ltd declares interim dividend of Rs. 4
  • IOL Chemicals and Pharmaceuticals Ltd receives EUGMP certification from Hungary authorities
  • IOL Chemicals and Pharmaceuticals Ltd receives patent
  • IOL Chemicals and Pharmaceuticals Ltd gets EDQM nod for Levetiracetam
  • IOL Chemicals and Pharmaceuticals Ltd commences commercial production of Paracetamol
  • IOL Chemicals and Pharmaceuticals Ltd declares interim dividend of Rs. 4
  • IOL Chemicals & Pharmaceuticals Ltd receives Korean FDA approval

Latest Post

  • Enviro Infra Engineers Reports 49.1% Revenue Growth to ₹ 3,592 Million in Q1 FY27; PAT Rises 6.5% to ₹ 452 Million
  • Wanbury Limited Reports Q1 FY27 Revenue of ₹165.6 Crore; Refinances ₹205 Crore Debt to Cut Interest Costs
  • Popular Vehicles & Services Reports 44.6% YoY Revenue Growth to ₹1,903.1 Crore in Q1 FY27; Turns Profitable with ₹1.4 Crore PAT
  • Hirect Limited Reports 20.3% Revenue Growth in Q1 FY27; Standalone Net Profit Up 17.8% Amid Global Expansion
  • Delton Cables reports highest ever first quarterly Revenue, EBITDA & PAT


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2025